Literature DB >> 41626

Anaesthetic management of phaeochromocytoma.

V Pratilas, M G Pratila.   

Abstract

The incidence, mortality, physiology, clinical findings and diagnosis of phaeochromocytoma are reviewed. Treatment, after adequate medical stabilization, must be surgical because of the high incidence of malignancy. Alpha-adrenergic receptor blockade and beta-adrenergic receptor blockade in the preoperative period was discussed. Anaesthetic management of patients with phaeochromocytoma requires close monitoring. Virtually all inhalational anaesthetic agents have been used in cases of phaeochromocytoma. Recent reports have favored enflurane. The merits of neuroleptanaesthesia and the various muscle relaxants are also discussed. Most authors favour lidocaine over propranolol for management of dysrhythmias during operation. Phentolamine or sodium nitroprusside are used for hypertension during operation. Hypotension is treated by fluid replacement with nor-epinephrine if a vasopressor becomes necessary. Close monitoring is necessary in the postoperative period. Adequate urinary output is of more importance than actual blood pressure levels.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 41626     DOI: 10.1007/bf03006283

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  39 in total

1.  [The influence of inhalation anaesthetics on catecholamine secretion from the adrenal medulla in vivo].

Authors:  M Göthert; D Bischoff; C Dreyer
Journal:  Anaesthesist       Date:  1975-01       Impact factor: 1.041

2.  Pheochromocytoma in the adult and in the child.

Authors:  D M HUME
Journal:  Am J Surg       Date:  1960-04       Impact factor: 2.565

3.  Urinary excretion of catecholamines and their metabolites in pheochromocytoma.

Authors:  J R CROUT; J J PISANO; A SJOERDSMA
Journal:  Am Heart J       Date:  1961-03       Impact factor: 4.749

4.  Pheochromocytoma; interesting experiences with three cases.

Authors:  R M MILES
Journal:  Ann Surg       Date:  1959-06       Impact factor: 12.969

5.  Anaesthesia in patients with phaeochromocytoma.

Authors:  L Stamenković; J Spierdijk
Journal:  Anaesthesia       Date:  1976-09       Impact factor: 6.955

6.  The acute cardiovascular changes and adrenergic blockade by droperidol in man.

Authors:  J G Whitwam; W J Russell
Journal:  Br J Anaesth       Date:  1971-06       Impact factor: 9.166

7.  Inhibitory effect of halothane anaesthesia on catecholamine release from the adrenal medulla.

Authors:  M Göthert; C Dreyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

Review 8.  Cardiac arrhythmias during anesthesia and operation.

Authors:  R L Katz; J T Bigger
Journal:  Anesthesiology       Date:  1970-08       Impact factor: 7.892

9.  Pheochromocytoma. Treatment with alpha- and beta-adrenergic blocking drugs.

Authors:  R M Crago; J W Eckholdt; J G Wismell
Journal:  JAMA       Date:  1967-11-27       Impact factor: 56.272

10.  Arrhythmic doses of epinephrine and dopamine during halothane, enflurane, methoxyflurane, and fluroxene anesthesia in goats.

Authors:  B Zahed; D J Miletich; A D Ivankovich; R F Albrecht; E T Toyooka
Journal:  Anesth Analg       Date:  1977 Mar-Apr       Impact factor: 5.108

View more
  5 in total

1.  Perioperative management of a patient with a malignant pheochromocytoma.

Authors:  D Miller; J A Robblee
Journal:  Can Anaesth Soc J       Date:  1985-05

2.  Unsuspected phaeochromocytoma presenting during surgery.

Authors:  D L Wooster; R I Mitchell
Journal:  Can Anaesth Soc J       Date:  1981-09

3.  Pediatric pheochromocytoma. A 36-year review.

Authors:  S H Ein; J Pullerits; R Creighton; J W Balfe
Journal:  Pediatr Surg Int       Date:  1997       Impact factor: 1.827

4.  Anaesthetic management with morphine in phaeochromocytoma.

Authors:  M Hamaji; N Oka; C Tashiro; T Seki; M Miyata; Y Kawashima
Journal:  Can Anaesth Soc J       Date:  1984-11

Review 5.  Protocol for presurgical and anesthetic management of pheochromocytomas and sympathetic paragangliomas: a multidisciplinary approach.

Authors:  M Araujo-Castro; E Pascual-Corrales; L Nattero Chavez; A Martínez Lorca; T Alonso-Gordoa; J Molina-Cerrillo; J Lorca Álvaro; C Mínguez Ojeda; S Redondo López; R Barberá Durbán; R Polo López; N Moreno Mata; U Caballero Silva; H Pian; I Ruz-Caracuel; A Sanjuanbenito Dehesa; V Gómez Dos Santos; A B Serrano Romero
Journal:  J Endocrinol Invest       Date:  2021-07-25       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.